Erin K. Rottinghaus

Erin K. Rottinghaus, J. Nkengasong, Chunfu Yang, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes

Reshma Kassanjee, Alex Welte, John Nkengasong, 2015, PloS one.

Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.

Erin K. Rottinghaus, Chunfu Yang, D. Zheng, 2015, AIDS research and human retroviruses.

Diagnosis of Human Immunodeficiency Virus Infection

A. Puren, Erin K. Rottinghaus, J. Nkengasong, 2018, Clinical Microbiology Reviews.

Virological response and HIV drug resistance 12 months after antiretroviral therapy initiation at 2 clinics in Nigeria.

Erin K. Rottinghaus, Chunfu Yang, J. Aberle‐grasse, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of Dried Blood Spots Collected on Filter Papers from Three Manufacturers Stored at Ambient Temperature for Application in HIV-1 Drug Resistance Monitoring

Erin K. Rottinghaus, E. Bile, Mosetsanagape Modukanele, 2014, PloS one.

Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.

J. Justman, Erin K. Rottinghaus, J. Nkengasong, 2019, AIDS research and human retroviruses.

Leveraging gains from African Center for Integrated Laboratory Training to combat HIV epidemic in sub-Saharan Africa

Erin K. Rottinghaus, J. Nkengasong, Chunfu Yang, 2021, BMC Health Services Research.

TLR-2 independent recognition of M. tuberculosis by CD11c + pulmonary cells from old mice

Erin K. Rottinghaus, J. Turner, B. Vesosky, 2011 .

CCL5 participates in early protection against Mycobacterium tuberculosis

G. Beamer, Erin K. Rottinghaus, J. Turner, 2010, Journal of leukocyte biology.